Logo
x

Search

Subscribe Now

All Posts by Date

Gilead Signs an Exclusive License Agreement with Rockefeller University for its Portfolio of HIV Abs

Gilead Signs an Exclusive License Agreement with Rockefeller University for its Portfolio of HIV Abs

  • January 10, 2020
Kaleido Signs a Collaboration with Janssen for Microbiome Metabolic Therapies (MMT)

Kaleido Signs a Collaboration with Janssen for Microbiome Metabolic Therapies (MMT)

  • January 10, 2020
Pfizer Signs an Exclusive Worldwide License Agreement with eFFECTOR to Develop Therapies for Cancer Indications

Pfizer Signs an Exclusive Worldwide License Agreement with eFFECTOR to Develop Therapies for Cancer Indications

  • January 10, 2020
Immunic Exercises its Worldwide Exclusive Option to License for IMU-856 with Daiichi Sankyo

Immunic Exercises its Worldwide Exclusive Option to License for IMU-856 with Daiichi Sankyo

  • January 10, 2020
Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

  • January 10, 2020
Eli Lilly to Acquire Dermira for $1.1B

Eli Lilly to Acquire Dermira for $1.1B

  • January 10, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.